
Soombit raises 12 billion won for CT and MRI imaging AI
The AMW Read
The round adds a medical imaging company to the player map and funds a product expansion, with impact concentrated in radiology.
Soombit raises 12 billion won for CT and MRI imaging AI
South Korean medical imaging AI company Soombit.ai has raised approximately 12 billion won, or $9 million, in a Series A led by SV Investment. Altos Ventures, Kiwoom Investment and iM Investment Partners also participated. The company was separately selected for a government Scale-up TIPS project that provides up to 3 billion won in research and development funding over three years. Soombit previously raised 5 billion won from Altos Ventures in 2024.
The funding supports Soombit's expansion beyond chest X-ray reading assistance into CT and MRI. Its AIRead-CT preliminary-reading product, which is under development, is intended to cover brain, chest and abdomen-pelvis scans. Soombit plans to unveil it at RSNA 2026 in Chicago and is targeting a 2027 launch. The move places the company in the medical imaging workflow market, where product development and regulatory clearance are both necessary steps toward commercialization. The announced expansion does not establish clinical performance or adoption for the new product.
For investors and builders, the next milestones are the AIRead-CT launch and the company's planned applications for US Food and Drug Administration clearance and European CE certification. Soombit says the government project will also support overseas regulatory and commercialization work. The company is hiring across research, software, business development and regulatory affairs as it develops in-house vision-language models for medical images, reports and clinical data.